|
 |
 |
|
|
 |
|
|
|
|
|
 |
|
|
 |
| Renal Resources includes: |
Discussion Board
Exercise Page
Medication
Nutrition Page
LifeStyle
Quality of life
Transplant
CKD
Diabetes
Dialysis
Political Issues
Reimbursement/Legal
Live Chat
Create an account
Login
|
 |
|
|
 |
|
|
 |
|
|
 |
|
|

|
|
 |
| 2009 Corporate Sponsors |
 |
 |
|
|
As the nation's largest operator of dialysis facilities, Fresenius Medical Services, a division of Fresenius Medical Care North America (FMCNA), is honored to serve as a leading contributor to the Shad Ireland Foundation. The company fully supports and endorses his efforts to inspire and motivate those individuals living with chronic kidney disease (CKD). Fresenius defines its UltraCare® mission as improving the quality of life of every patient, every treatment. This is accomplished through innovative programs, the latest technology and a focus on superior customer service. Nationwide, FMCNA operates approximately 1,600 dialysis facilities treating 117,000 patients. It is also the nation’s leading provider of dialysis products, including dialysis machines, dialyzers and related disposable products.
For additional information on FMCNA dialysis services and the clinic nearest you, call 1.866.4.DIALYSIS (1.866.434.2597) or visit www.ultracare-dialysis.com. |
About Amgen Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disorder, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit http://www.amgen.com. |
ENDURO SPORT
coming soon. |
cervélo
Coming soon. |
|
|
|